Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scent dogs can detect coronavirus on human skin swabs - study
The dogs were able to accurately sniff-out coronavirus infection 92 per cent of the time.

The dogs correctly identified the samples 92 per cent of the time.

Dogs can be trained to detect coronavirus infection from human skin swabs, according to new research.

In a three-part study, researchers at the University of Helsinki and Helsinki University Hospital found that trained scent dogs could accurately detect coronavirus in more than 90 per cent of samples. 

Scientists say their findings, published in the journal BMG Global Health, provide valuable information on the use of scent dogs in pandemic control. 

Anu Kantele, a professor of infectious diseases and chief physician at the University of Helsinki and Helsinki University Hospital, commented: "Scent dogs can provide an invaluable tool for limiting viral spread during a pandemic, serving, for example, at air- and seaports.

"Such a reliable, cheap approach to rapidly screen a vast number of samples or to identify passing virus carriers from a large crowd is of value, particularly when the testing capacity with traditional approaches is insufficient".

In the study, the team first trained the dogs to distinguish between skin swab samples from coronavirus patients and volunteers who tested negative. The dogs were then transferred from the training facility to Helsinki-Vantaa Airport.

Next, four of the trained dogs completed a validation test to prove their discriminatory ability. This experiment involved the team presenting the dogs with 420 samples over the course of a week.

The team found that the dogs could correctly identify the coronavirus samples 92 per cent of the time, only observing minor differences in accuracy. Virus variations were the most significant factor in the dogs incorrectly recognising the samples. 

Phase three saw the dogs enter a real-life situation, screening passengers and staff at the airport. In this experiment, the dogs correctly identified 98.7 per cent of the negative samples. 

The team explains that the low number of coronavirus samples helped them to assess the dogs’ performance with positive samples. They gave the dogs ‘work motivation samples’ at regular intervals to maintain their interest in the target odour.

'Work motivation samples' are samples pre-collected from PCR positive patients but not previously sniffed by dogs. From these, the dogs were able to accurately identify the virus 98.7 per cent of the time.

Anna Hielm-Björkman, a senior clinical instructor from the University of Helsinki, said: "Our research group will continue to study how scent dogs can best help our society. We hope that this newly published study will help to allocate funds for the development of this new ‘tool’.

"There are many other diseases where research could benefit from the excellent sense of smell that these dogs possess".

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.